Scientists discover migrions that accelerate viral infections

Researchers have identified migrions, virus-like structures that enable faster and more severe viral spread by hijacking cell movement. These packages, formed in migrating cells infected with vesicular stomatitis virus, deliver multiple viral genomes simultaneously to new cells. The discovery challenges traditional models of infection and highlights increased disease potential in animal tests.

A team from Peking University Health Science Center and the Harbin Veterinary Research Institute has revealed a novel mechanism of viral transmission detailed in a study published in Science Bulletin. The research focuses on vesicular stomatitis virus (VSV), where infected cells pack viral genetic material and proteins into migrasomes—cellular structures that emerge during cell migration.

These migrasomes, containing viral nucleic acids and displaying the VSV surface protein VSV-G, form large virus-like entities dubbed "migrions." Unlike individual virus particles, migrions combine viral and cellular components, allowing for collective delivery. This bundling enables quicker replication in recipient cells, as multiple viral genomes arrive at once, initiating parallel infection processes.

Migrions stand out for their ability to transport more than one virus type simultaneously, differing from standard extracellular vesicle transmission. Upon reaching a new cell, they enter via endocytosis. Acidic conditions inside then activate VSV-G, prompting fusion with endosomes and release of viral contents to kickstart replication.

In mouse experiments, migrion-mediated infections proved far more potent than free virus exposure. Affected animals suffered severe lung and brain conditions, including encephalitis, often leading to fatal outcomes. This underscores the heightened pathogenicity of the migration-linked route.

The researchers describe migrions as a chimeric structure bridging viruses and migrasomes, introducing a migration-dependent transmission model. By exploiting the body's migratory systems, viruses can propagate more efficiently and systemically, potentially explaining rapid escalations in certain infections.

Awọn iroyin ti o ni ibatan

Realistic microscopic illustration of influenza viruses surfing along a human cell membrane before entry.
Àwòrán tí AI ṣe

Scientists film influenza viruses ‘surfing’ into human cells in real time

Ti AI ṣe iroyin Àwòrán tí AI ṣe Ti ṣayẹwo fun ododo

An international team led by ETH Zurich and including researchers in Japan has used a new high‑resolution imaging technique to watch, live, as influenza viruses penetrate human cells. The work shows that cells actively engage with the virus, helping to draw it inside in a process that resembles surfing along the cell membrane, and could inform the development of targeted antiviral therapies.

A new study reveals that giant viruses, like the mimivirus, encode parts of the cellular protein-making machinery, allowing them to direct their amoeba hosts more effectively. This capability blurs the line between living and non-living entities. Researchers suggest it enhances viral production even under stressful conditions.

Ti AI ṣe iroyin

Scientists in Japan have discovered a giant virus called ushikuvirus that infects amoebae and provides evidence for the theory that viruses contributed to the evolution of complex cells. Isolated from Lake Ushiku, the virus exhibits unique structural and replication traits linking it to other giant DNA viruses. This finding, published in the Journal of Virology, deepens understanding of viral roles in eukaryotic evolution.

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Ti AI ṣe iroyin

Researchers report that a single injection of a modified herpes virus draws immune cells deep into glioblastoma tumors, leading to longer survival in a clinical trial. The therapy, tested on 41 patients with recurrent brain cancer, activates T cells that persist and attack cancer cells. Findings were published in Cell.

Scientists at the University of Queensland have captured the first near‑atomic, high‑resolution 3D images of the yellow fever virus, detailing how the surface of the long‑used vaccine strain differs from virulent, disease‑causing strains. The work sheds light on how the virus is recognised by the immune system and could support improved vaccines for yellow fever and related mosquito‑borne diseases.

Ti AI ṣe iroyin Ti ṣayẹwo fun ododo

Researchers at Washington University School of Medicine in St. Louis, working with scientists at Northwestern University, have developed a noninvasive nasal nanotherapy that activates the immune system to attack aggressive brain tumors in mice. By delivering spherical nucleic acids that trigger the STING immune pathway directly from the nose to the brain, the approach eliminated glioblastoma tumors in mouse models when combined with drugs that boost T-cell activity, according to a study in the Proceedings of the National Academy of Sciences.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ